SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-16-007318
Filing Date
2016-06-08
Accepted
2016-06-08 11:50:42
Documents
67
Period of Report
2016-04-30

Document Format Files

Seq Description Document Type Size
1 c85140_10q.htm 10-Q 591627
2 c85140_ex10-1.htm EX-10.1 91443
3 c85140_ex10-2.htm EX-10.2 202338
4 c85140_ex31-1.htm EX-31.1 9260
5 c85140_ex31-2.htm EX-31.2 9254
6 c85140_ex32-1.htm EX-32.1 3039
7 c85140_ex32-2.htm EX-32.2 3061
  Complete submission text file 0000930413-16-007318.txt   4489591

Data Files

Seq Description Document Type Size
8 enz-20160430.xml EX-101.INS 925654
9 enz-20160430.xsd EX-101.SCH 57231
10 enz-20160430_cal.xml EX-101.CAL 43898
11 enz-20160430_def.xml EX-101.DEF 227120
12 enz-20160430_lab.xml EX-101.LAB 347593
13 enz-20160430_pre.xml EX-101.PRE 239349
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 161703004
SIC: 8071 Services-Medical Laboratories